Surgalign Holdings, Inc. Common Stock
SRGA
SRGA was delisted on the 30th of June, 2023.
89 hedge funds and large institutions have $49.1M invested in Surgalign Holdings, Inc. Common Stock in 2021 Q3 according to their latest regulatory filings, with 20 funds opening new positions, 18 increasing their positions, 29 reducing their positions, and 20 closing their positions.
0% more funds holding
Funds holding: 89 → 89 (0)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0% more first-time investments, than exits
New positions opened: 20 | Existing positions closed: 20
38% less repeat investments, than reductions
Existing positions increased: 18 | Existing positions reduced: 29
39% less capital invested
Capital invested by funds: $80.2M → $49.1M (-$31.1M)
53% less call options, than puts
Call options by funds: $132K | Put options by funds: $282K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Assenagon Asset Management
Senningerberg,
Luxembourg
|
+$3.37M |
| 2 |
Fuller & Thaler Asset Management
San Mateo,
California
|
+$862K |
| 3 |
Two Sigma Investments
New York
|
+$654K |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$523K |
| 5 |
CLG
Cooperman Leon G
|
+$523K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TC
TownSquare Capital
Provo,
Utah
|
-$4.56M |
| 2 |
ACM
Archon Capital Management
Seattle,
Washington
|
-$3.48M |
| 3 |
ICM
Invenomic Capital Management
Boston,
Massachusetts
|
-$3.27M |
| 4 |
Renaissance Technologies
New York
|
-$2.44M |
| 5 |
ACM
Altium Capital Management
New York
|
-$2.42M |
SRGA Hedge Fund Activity: Q3 2021 in Review
89 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in Surgalign Holdings, Inc. Common Stock (SRGA) for Q3 2021, worth a combined $49.1M — down 39% from $80.2M a quarter earlier.
Fund positioning in SRGA was balanced in Q3 2021: 20 funds opened new positions, 20 closed out, 18 added to existing stakes and 29 trimmed.
The largest buyer was Assenagon Asset Management, adding an estimated $3.37M. The largest seller was TownSquare Capital, cutting an estimated $4.56M.
- 89 institutional investors held Surgalign Holdings, Inc. Common Stock (SRGA) as of Q3 2021, unchanged from Q2 2021.
- Funds reported $49.1M of Surgalign Holdings, Inc. Common Stock stock for Q3 2021, down 39% quarter-over-quarter.
- 20 funds opened new Surgalign Holdings, Inc. Common Stock positions in Q3 2021 and 20 closed out, a net change of 0 holders.
- The largest Surgalign Holdings, Inc. Common Stock buyer in Q3 2021 was Assenagon Asset Management, an estimated $3.37M added.
- The largest Surgalign Holdings, Inc. Common Stock seller in Q3 2021 was TownSquare Capital, an estimated $4.56M sold.
Based on aggregated 13F filings for Q3 2021.